TrialPath

22 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

18 studies on the map

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease — Banner Alzheimer's Institute, PhoenixTreat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission — Hoag Hospital, IrvinePiMZ Longitudinal Cohort (PiMZ Logic) — University of Alabama at Birmingham, BirminghamProspective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod — University of Colorado Anschutz Medical Campus, AuroraOpen-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD — Digestive & Liver Center of Florida, OrlandoBehavioral Therapy for Crohn's Disease — Icahn School of Medicine at Mount Sinai, New YorkStudy of Novel Therapeutics for Acute Remedy of Colitis — Brigham and Women's Hospital, Chestnut HillFeasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD — University of Tennessee Medical Center, KnoxvilleNeurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD — John D. Dingell VA Medical Center, Detroit, MI, DetroitInter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction — Beth Israel Deaconess Medical Center, BostonNHALES (Natural History of Asthma With Longitudinal Environmental Sampling) — NIEHS Clinical Research Unit (CRU), Research Triangle ParkIntervention for Communication Quality of Life in Primary Progressive Aphasia — University of Texas, AustinInvestigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1 — Washington University School of Medicine, St LouisIndividual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease — Massachusetts General Hospital, CharlestownThis Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis. — Washington University in St. Louis, St LouisFermented Food-Supplemented Diet in Ulcerative Colitis — Stanford University, Palo AltoTreatment of UC With Novel Therapeutics — Brigham and Women's Hospital, Chestnut HillThe Influence of a Fasting Mimicking Diet on Ulcerative Colitis — Stanford University, Palo Alto